[go: up one dir, main page]

BRPI0509374A - suplementos nutricionais multivitamìnicos e minerais - Google Patents

suplementos nutricionais multivitamìnicos e minerais

Info

Publication number
BRPI0509374A
BRPI0509374A BRPI0509374-0A BRPI0509374A BRPI0509374A BR PI0509374 A BRPI0509374 A BR PI0509374A BR PI0509374 A BRPI0509374 A BR PI0509374A BR PI0509374 A BRPI0509374 A BR PI0509374A
Authority
BR
Brazil
Prior art keywords
supplement
cholesterol
multivitamin
mineral
nutritional supplements
Prior art date
Application number
BRPI0509374-0A
Other languages
English (en)
Inventor
Michael G Williams
William A Bubnis
Richard Cotter
Paul W Herman
Judith Moreines
Scott W Poxon
Bruce W Sutton
Jeffrey V Vernon
Denise L Walters
Neil Wittenberg
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35064300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0509374(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0509374A publication Critical patent/BRPI0509374A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"SUPLEMENTOS NUTRICIONAIS MULTIVITAMìNICOS E MINERAIS". A presente invenção proporciona um suplemento nutricional que inclui micronutrientes para facilitar redução de colesterol, e/ou redução de homocisteína e/ou redução de oxidação de colesterol lipoproteína de baixa densidade (LDL-C) em seres humanos. Em uma modalidade, o suplemento é um suplemento multivitamínico ou um suplemento mineral que inclui pelo menos um componente sabido reduzir colesterol. A invenção proporciona adicionalmente um método para produzir comprimidos de um quarto a metade da dosagem eficaz diária de um suplemento nutricional que contém fitosterol em um comprimido dimensionado de forma prática, e um método para reduzir colesterol sangüíneo em seres humanos.
BRPI0509374-0A 2004-03-29 2005-03-28 suplementos nutricionais multivitamìnicos e minerais BRPI0509374A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55724704P 2004-03-29 2004-03-29
PCT/US2005/010467 WO2005094333A2 (en) 2004-03-29 2005-03-28 Multi-vitamin and mineral nutritional supplements

Publications (1)

Publication Number Publication Date
BRPI0509374A true BRPI0509374A (pt) 2007-09-11

Family

ID=35064300

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509374-0A BRPI0509374A (pt) 2004-03-29 2005-03-28 suplementos nutricionais multivitamìnicos e minerais

Country Status (21)

Country Link
US (3) US20050214383A1 (pt)
EP (1) EP1732605B1 (pt)
KR (2) KR101389061B1 (pt)
CN (1) CN1956734B (pt)
AR (1) AR048450A1 (pt)
AU (1) AU2005228421B8 (pt)
BR (1) BRPI0509374A (pt)
CA (2) CA2560595C (pt)
DK (1) DK1732605T3 (pt)
DO (1) DOP2005000047A (pt)
ES (1) ES2733455T3 (pt)
HU (1) HUE044810T2 (pt)
MY (1) MY151326A (pt)
PE (1) PE20051166A1 (pt)
PL (1) PL1732605T3 (pt)
PT (1) PT1732605T (pt)
RU (1) RU2375079C2 (pt)
TR (1) TR201909238T4 (pt)
TW (1) TWI457079B (pt)
WO (1) WO2005094333A2 (pt)
ZA (1) ZA200608092B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020252545A1 (pt) * 2019-06-18 2020-12-24 Farmoquímica S/A Composição nutracêutica combinando probióticos, vitaminas e minerais

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101389061B1 (ko) * 2004-03-29 2014-04-28 와이어쓰 엘엘씨 종합비타민 및 무기물 영양 보충제
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060292217A1 (en) * 2005-06-03 2006-12-28 Schmidt Robbin D Nutritional supplement and soft gelatin capsule delivery system
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US20090220619A1 (en) * 2006-04-05 2009-09-03 Wyeth Nutritional formulation
US7879375B1 (en) * 2006-06-23 2011-02-01 Arizona Pharmaceuticals, LLC Pharmaceutical composition
US7998476B2 (en) 2006-11-22 2011-08-16 Standard Biologics, Inc. Method of treatment using Aspergillus oryzae protease
CA2718571A1 (en) * 2007-03-12 2008-09-18 Pipex Pharmaceuticals, Inc. Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
US7794758B2 (en) * 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US8394425B2 (en) * 2007-04-05 2013-03-12 Pmc Formulas, Inc. Methods for promoting cellular health and treatment of cancer
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
EP2220208A4 (en) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res USE OF HAPTOGLOBIN ENTYPIZATION FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
US20110015277A1 (en) * 2007-12-17 2011-01-20 Wilhelmus Johannes Gertrudes Thielen Method of producing egg yolk based functional food product and products obtainable thereby
US20090163452A1 (en) * 2007-12-20 2009-06-25 Schwartz Janice B Compositions and methods for lowering serum cholesterol
US8440181B2 (en) * 2008-02-07 2013-05-14 Ralph Brown Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult
WO2010056318A2 (en) * 2008-11-12 2010-05-20 Andrew Loblaw Nutritional supplement
RU2663017C2 (ru) * 2009-01-23 2018-08-01 ВАЙЕТ ЭлЭлСи Пищевые добавки для лиц в возрасте 50 лет и старше для повышения жизнеспособности, иммунитета, здоровья глаз и костей
SG10201800064UA (en) * 2009-01-23 2018-02-27 Wyeth Llc A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effect
US8247000B2 (en) 2009-04-10 2012-08-21 Cypress Pharmaceutical, Inc. Phosphate-binding magnesium salts and uses thereof
AR076576A1 (es) * 2009-05-13 2011-06-22 Wyeth Llc Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos
US8911770B2 (en) * 2009-06-18 2014-12-16 Alessandra Grassi Dissolvable dietary supplement strip and methods for using the same
US20110135753A1 (en) * 2009-12-04 2011-06-09 John Wigneswaran Nutritional Supplement For Patients With Chronic Heart Failure
US20110142766A1 (en) * 2009-12-16 2011-06-16 Sal Rafanelli Effervescent Multi-Vitamin Formulation and Methods of Use Thereof
US20120329764A1 (en) * 2010-01-08 2012-12-27 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the treatment of migraine headaches
CN101785854B (zh) * 2010-02-11 2012-10-31 石家庄惠仕医药保健品有限公司 叶黄素多维营养保健药物组合物、其制备方法及应用
WO2011112117A1 (ru) * 2010-03-12 2011-09-15 Kolesnik Aleksei Yuryevich Премикс для пищевых продуктов
RU2423108C1 (ru) * 2010-04-12 2011-07-10 Михаил Иванович Лазарев Оптимизированный витаминно-минеральный комплекс
GB201014340D0 (en) * 2010-08-27 2010-10-13 Piraee Mahmood Nutritional supplement formulation comprising saffron and resveratrol
CN101982115A (zh) * 2010-10-14 2011-03-02 张丽娜 一种防治糖尿病慢性糖中毒的组合物
WO2012078597A1 (en) * 2010-12-07 2012-06-14 Freeman Steven R Vegetable based tobacco alternatives and articles comprising same
US8846061B1 (en) 2011-03-08 2014-09-30 Mark S. Bezzek Multivitamin-mineral regimens for longevity and wellness
FR2972330B1 (fr) * 2011-03-08 2015-01-16 Lab Attitude Composition nutraceutique pour limiter l'absorption de lipides alimentaires et pour induire une perte de poids comprenant comme agent actif au moins un extrait de carotte.
US8343517B1 (en) 2011-03-08 2013-01-01 Bezzek Mark S Multivitamin-mineral longevity regimen
US8460718B2 (en) * 2011-04-07 2013-06-11 Lycored Ltd. Synergistic compositions and methods
KR101840082B1 (ko) * 2011-05-03 2018-03-19 알파시그마 에스.피.에이. 지질 대사 장애의 치료에 유용한 조성물
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
GB201121519D0 (en) * 2011-12-14 2012-01-25 Ip Science Ltd Fat-based food products
EA025844B1 (ru) * 2012-05-08 2017-02-28 Общество С Ограниченной Ответственностью "Лигур-М" Средство для коррекции гиперхолестеринемии
CN102919856A (zh) * 2012-10-31 2013-02-13 郑州凯利药业有限公司 一种营养素补充剂
US9394318B2 (en) 2012-11-30 2016-07-19 Cypress Pharmaceuticals, Inc. Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
WO2014145072A1 (en) * 2013-03-15 2014-09-18 Everett Laboratories, Inc. Gummy compositions for nutritional supplementation
GB2512314A (en) * 2013-03-26 2014-10-01 Kartar Singh Lalvani Statin composition
US9801821B2 (en) 2013-03-27 2017-10-31 Psm Healthcare Limited Stabilized vitamin D formulations
ITRM20130237A1 (it) * 2013-04-19 2013-07-19 Pelliccia Francesco Formulazione per somministrazione orale di una combinazione di integratori alimentari utile per favorire corretti livelli di colesterolo
US20160053281A1 (en) * 2013-08-15 2016-02-25 The University Court Of The University Of Edinburgh Enhanced Expression Of RNA Vectors
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
EP3094380B1 (en) * 2014-01-17 2021-04-28 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
EP2915434A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for increasing human growth hormone and nitric oxide production
EP2915431A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for the mind
EP2915433A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for energy
CA3176253A1 (en) 2014-11-19 2016-05-26 Rush University Medical Center Use of cinnamic acid or sodium benzoate for treating lysosomal disorders
CH710567A1 (de) * 2014-12-30 2016-06-30 Häcki Simone Haarwuchspräparat bzw. Nahrungsergänzungsmittel.
US10863762B2 (en) * 2015-02-26 2020-12-15 Cura Global Health (Bvi) Limited Mineral enriched natural supplements
BR112018007634A2 (pt) * 2015-10-16 2018-11-06 Dee Kennie tablete oral revestido estável
US10617700B1 (en) 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10039765B1 (en) 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
ES2914650T3 (es) 2016-04-27 2022-06-15 Abergavenny Nv Sal de butirato de colina
CN107441117A (zh) * 2016-05-30 2017-12-08 上海诺成药业股份有限公司 一种多维元素钙制剂及其制备方法
US11344575B2 (en) 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment
US11357250B2 (en) 2016-08-15 2022-06-14 Summit Innovation Labs LLC Treatment and prevention of diabetes and obesity
EP3528892A4 (en) 2016-10-24 2020-07-01 Callion Pharma ANTIOXIDANT-ENHANCED MULTIVITAMIN COMPOSITION AND METHODS OF USE
CN106723066A (zh) * 2017-01-12 2017-05-31 浙江格蕾斯生物科技有限公司 一种硼硒和多种维生素复合添加剂
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
WO2021108527A1 (en) * 2019-11-25 2021-06-03 Lian xu li Dietary supplement
USD914868S1 (en) * 2020-04-23 2021-03-30 Access Business Group International Llc. Supplement tablet
KR102271734B1 (ko) 2020-10-21 2021-07-01 한국프라임제약주식회사 건식과립공정용 멀티비타민 약제학적 조성물
DE102021117780A1 (de) 2021-07-09 2023-01-12 Aixbio Gmbh Biomimetisches Nahrungsergänzungsmittel
DE202022106411U1 (de) 2022-11-15 2022-11-21 Aixbio Gmbh Biomimetisches Nahrungsergänzungsmittel

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4021582A (en) * 1976-02-13 1977-05-03 Societe D'assistance Technique Pour Produits Nestle S.A. Water-dispersible composition and process for production
US4588717A (en) * 1984-06-13 1986-05-13 David C. Mitchell Medical Research Institute Compounds and vitamin supplements and methods for making same
US6544973B1 (en) * 1995-07-28 2003-04-08 Raisio Benecol Ltd. Substance for lowering high cholesterol level in serum and methods for preparing and using the same
FR2693876A1 (fr) * 1992-07-24 1994-01-28 Vani Complément nutritif à base de micronutriments.
CH685283A5 (it) 1993-09-21 1995-05-31 Inpharma Sa Composizioni dietetiche ipocolesterolemizzanti.
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US6139832A (en) 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
WO1997006790A1 (en) * 1995-08-14 1997-02-27 Oxigene, Inc. Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
DE69636119T2 (de) * 1995-09-18 2006-11-30 Daikin Industries, Ltd. Gefülltes körniges polytetrafluorethylenpulver und verfahren zur ihrer herstellung
CA2251972A1 (en) * 1996-04-17 1997-10-23 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
US6673831B1 (en) * 1996-04-17 2004-01-06 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
US5932561A (en) * 1997-10-24 1999-08-03 Rexall Sundown, Inc. Dietary composition with lipid binding properties for weight management and serum lipid reduction
DK1037607T3 (da) * 1997-12-08 2004-06-21 Altana Pharma Ag Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse
US5952393A (en) * 1998-02-12 1999-09-14 Sorkin, Jr.; Harlan Lee Composition for reducing serum cholesterol levels
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
FI111513B (fi) * 1998-05-06 2003-08-15 Raisio Benecol Oy Uudet fytosteroli- ja fytostanolirasvahappoesterikoostumukset, niitä sisältävät tuotteet sekä menetelmät niiden valmistamiseksi
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
ZA994696B (en) * 1998-09-09 2000-01-31 Pharmachoice Healthcare Pty Lt Nutritional healthcare formulation.
WO2000015201A2 (en) 1998-09-10 2000-03-23 Forbes Medi-Tech Inc. Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders
US6274170B1 (en) * 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
US6914073B2 (en) * 1999-03-18 2005-07-05 Bristol Myers Squibb Company Vitamin formulation for cardiovascular health
WO2001000653A1 (en) * 1999-06-23 2001-01-04 Forbes Medi-Tech Inc. Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
EP1189522B1 (de) * 1999-06-25 2005-09-21 Cognis IP Management GmbH Verwendung von nanoskaligen sterolen und sterolestern
US6197832B1 (en) * 1999-09-14 2001-03-06 Harlan Lee Sorkin, Jr. Composition for reducing serum cholesterol levels
JP4381543B2 (ja) * 2000-02-17 2009-12-09 株式会社ファンケル 食品組成物及びその製造方法
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6299896B1 (en) * 2000-04-13 2001-10-09 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6610320B2 (en) * 2000-04-14 2003-08-26 Mars, Incorporated Compositions and methods for improving vascular health
US7147859B2 (en) * 2000-05-15 2006-12-12 Laboratorios Biosintetica Ltda. Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
BR0001794A (pt) * 2000-05-15 2001-12-26 Laboratorios Biosintetica Ltda Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
US20030165572A1 (en) * 2000-09-01 2003-09-04 Nicolas Auriou Water-dispersible encapsulated sterols
US6576285B1 (en) * 2000-11-14 2003-06-10 Sunpure Ltd. Cholesterol lowering beverage
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
US6933291B2 (en) 2000-12-01 2005-08-23 N.V. Nutricia Cholesterol lowering supplement
US20030096018A1 (en) * 2000-12-15 2003-05-22 Schloss Caroline Maxine Multi-vitamin and hormone replacement supplement
ME00145B (me) * 2001-01-26 2010-10-10 Merck Sharp & Dohme Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
ES2289097T3 (es) * 2001-03-15 2008-02-01 Dsm Ip Assets B.V. Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados.
US7090862B2 (en) * 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6787151B2 (en) * 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
CA2463495C (en) * 2001-10-12 2011-05-24 Elan Pharma International Ltd. Compositions having a combination of immediate release and controlled release characteristics
US20040018248A1 (en) 2001-11-29 2004-01-29 Adrianne Bendich Composition containing statins and calcium for improved cardiovascular health
WO2003090723A1 (en) * 2002-04-23 2003-11-06 Bristol-Myers Squibb Company Modified-release vasopeptidase inhibitor formulation, combinations and method
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
US20040033202A1 (en) * 2002-06-10 2004-02-19 Elan Pharma International, Ltd. Nanoparticulate sterol formulations and novel sterol combinations
AU2003245313A1 (en) 2002-06-10 2003-12-22 Elan Pharma International, Ltd Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
US6953588B2 (en) * 2002-10-25 2005-10-11 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
RU2237487C2 (ru) * 2002-12-19 2004-10-10 Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" Препарат "кандифит"
DE20316876U1 (de) 2003-11-03 2004-02-05 China Vital Med E.K. Nahrungsergänzungsmittel
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
KR101389061B1 (ko) * 2004-03-29 2014-04-28 와이어쓰 엘엘씨 종합비타민 및 무기물 영양 보충제
US20080103118A1 (en) * 2006-10-27 2008-05-01 Iomedix Development International Srl Composition for improving blood cholesterol levels
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US20080254119A1 (en) * 2007-04-16 2008-10-16 Wyeth Imbedded liquid lubricants for tableting
CA2691691C (en) * 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020252545A1 (pt) * 2019-06-18 2020-12-24 Farmoquímica S/A Composição nutracêutica combinando probióticos, vitaminas e minerais

Also Published As

Publication number Publication date
US20140017312A1 (en) 2014-01-16
CN1956734A (zh) 2007-05-02
TW200538054A (en) 2005-12-01
AU2005228421B8 (en) 2011-11-17
AR048450A1 (es) 2006-04-26
CA2560595A1 (en) 2005-10-13
AU2005228421B2 (en) 2011-07-21
PE20051166A1 (es) 2006-02-13
WO2005094333A2 (en) 2005-10-13
PL1732605T3 (pl) 2019-09-30
KR20060135042A (ko) 2006-12-28
CA2560595C (en) 2013-01-22
US20050214383A1 (en) 2005-09-29
TR201909238T4 (tr) 2019-07-22
RU2375079C2 (ru) 2009-12-10
CN1956734B (zh) 2012-10-10
WO2005094333A3 (en) 2006-02-16
WO2005094333A8 (en) 2006-01-05
EP1732605A4 (en) 2009-05-27
DK1732605T3 (da) 2019-06-11
KR101389061B1 (ko) 2014-04-28
ES2733455T3 (es) 2019-11-29
EP1732605A2 (en) 2006-12-20
KR101573316B1 (ko) 2015-12-01
US8927012B2 (en) 2015-01-06
RU2006138056A (ru) 2008-05-10
CA2794424C (en) 2019-06-04
PT1732605T (pt) 2019-07-12
CA2794424A1 (en) 2005-10-13
US20110223250A1 (en) 2011-09-15
ZA200608092B (en) 2008-04-30
EP1732605B1 (en) 2019-05-08
HUE044810T2 (hu) 2019-11-28
AU2005228421A1 (en) 2005-10-13
MY151326A (en) 2014-05-15
KR20120136418A (ko) 2012-12-18
TWI457079B (zh) 2014-10-21
DOP2005000047A (es) 2005-11-15

Similar Documents

Publication Publication Date Title
BRPI0509374A (pt) suplementos nutricionais multivitamìnicos e minerais
GB2458466A (en) Composition for hair, skin and nail health maintenance
WO2006044101A3 (en) Method and composition for supplementation of nutritional deficiencies in renal patients
WO2008071790A3 (en) Novel compositions and uses thereof
GB2585619A (en) A supplement
Sato et al. RETRACTED: Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine
WO2002026221A3 (en) Method and composition for supplementation of nutritional deficiencies in renal patients
Sutanto et al. The impact of 5-hydroxytryptophan supplementation on sleep quality of older adults in Singapore: a randomized controlled trial
JP2015007092A (ja) 大量の栄養補給剤の負の副作用なしに、環境ストレスの作用に対抗し、免疫を改善し、活動力を改善し、一方でビタミンおよび無機質の欠乏に対処するための、マルチビタミン／無機質配合物
Korah et al. Adverse effects and side effects on vitamin therapy: a review
CL2004000813A1 (es) Composicion farmaceutica o dietetica que comprende vitaminas, minerales, oligoelementos, acido docosahexanoico (dha) y un vehiculo apropiado, su uso y metodo para suplementar las necesidades dieteticas de una mujer que esta amamantando, esta embaraza
WO2007149816A3 (en) Strontium compositions and methods of treating osteoporotic conditions
WO2011041920A8 (es) Composición nutracéutica que comprende extracto de shilajit, ácido fólico, vitamina b12 y vitamina b6 y su uso para prevenir y/o tratar enfermedades neurodegenerativas y/o el deterioro cognitivo asociado al envejecimiento cerebral
UA94975C2 (ru) Композиция и ее применение для лечения гипергликемии и связанных с ней болезней
Bries et al. Assessment of Gastrointestinal Symptoms and Non-transferrin Bound Iron After Oral Ferrous Sulfate and Iron-enriched Aspergillus Oryzae Supplementation in Women (P24-039-19)
Gheller et al. Safety of graded-doses of histidine in healthy adults (P08-062-19)
Menon et al. Multivitamins: use or misuse?
Wayne et al. Nilotinib treatment in pediatric patients (pts) with Philadelphia chromosome-positive (Ph+) leukemia refractory to prior tyrosine kinase inhibitor (TKI) therapy: results from nilotinib compassionate use program
Chen et al. Cardiovascular disease protective effect of allicin through gut microbiota modulation (FS07-08-19)
Zuchniak et al. Effect of vitamin D supplementation during pregnancy on blood concentrations of toxic metals (P24-063-19)
Bos et al. Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.
Botsalı Vitamin A/B/C in Dermatology
Davis et al. Wheat Extract Oil (WEO) Attenuates UVB-Induced Photoaging via Collagen Synthesis in Human Keratinocytes and Hairless Mice
Teplan et al. Effect of keto amino acids on asymmetric dimethyl arginine, muscle and fat tissue in chronic kidney disease
WO2007050599A8 (en) Ginkgolides in the treatment and prevention of ovarian cancer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]